Oncoinvent, ASA Oncoinvent ASA half-yearly report: Strong focus on financial discipline and advancing Phase 2 program in ovarian cancer 27.08.2025 - 07:35:32 Oncoinvent AS Norway View original content:https://www.prnewswire.co.uk/news-releases/oncoinvent-asa-half-yearly-report-strong-focus-on-financial-discipline-and-advancing-phase-2-program-in-ovarian-cancer-302539752.html
